An Interview with Peter Nakada of RMS
Peter Nakada is a Managing Director, capital markets at Risk Management Solutions (RMS). We had a chance to speak to Peter about...
- Read more about An Interview with Peter Nakada of RMS
- Log in to post comments
Peter Nakada is a Managing Director, capital markets at Risk Management Solutions (RMS). We had a chance to speak to Peter about...
S. Jay Olshansky is a Professor in the School of Public Health at the University of Illinois at Chicago and Research Associate at the Center on Aging at the University of Chicago and at the London School of Hygiene and Tropical Medicine. Much of Dr. Olshanky's research has focused on the upper limits to human longevity and the health and public policy implications associated with aging. We had an opportunity to connect with Jay at the recent SOA Living to 100 Symposium.
AD: As an expert in...
AD: Your book Calculating Catastrophe discusses the dynamic nature of catastrophe risks, and you have written elsewhere about how...
- The value of health and longevity -- ”a 1 percent reduction in cancer mortality would be worth $500 billion” (Dartmouth College)
- 2 formulas intended to optimize annual retirement withdrawal strategy -- 1 approach is dynamic and the other is based on...
- Buffett and Berkshire adding equity exposure to defined benefit...
Advisor Perspectives just published the first in a series of articles from Wade Pfau. These pieces are important and should be read by anyone considering guaranteed lifetime withdrawal benefits or any of the other optional...
Duration is a measure of the time associated with cash flows or payments from a bond. Duration measures the amount of time (in years from the purchase date) required for a bond owner to receive interest and principal payments that are equal to the cost of the bond.
Long duration bonds have payments that are spread-out over a relatively long period of time (e.g...